South West London Pathology Picks CliniSys for Next Generation LIMS

CliniSys One of the first pathology networks in the country, set up to serve more than two million people in south west London, has signed a contract with CliniSys for a new laboratory information management system (LIMS). South West London Pathology, which was established in 2014, is now working with the company to prepare to deploy WinPath Enterprise.

The award-winning NHS pathology networkwas set up by St George's University Hospitals NHS Foundation Trust, Croydon Health Services NHS Trust and Kingston Hospital NHS Foundation Trust to provide a single, integrated pathology service across south west London and beyond.

It operates on a ‘hub and spoke’ model, with a main hub laboratory at St George's Hospital and spoke sites at Croydon and Kingston to manage urgent local work.

The new LIMS will replace the mix of legacy systems used by the different services run out of these labs, including the iLab APEX LIMS at St George’s and older versions of WinPath used at Kingston and Croydon.

WinPath Enterprise is a next generation LIMS, designed to meet the requirements of the growing number of pathology networks that are being set up to improve the availability and efficiency of clinical tests for NHS providers.

Its deployment by South West London Pathology will enable all the network’s sites to use a single database, with better reporting and analytics tools. The roll-out of the new system will be phased andthe aim is to make the first service live by the end of 2019 and all sites and services live within 18 months.

Simon Brewer, managing director of South West London Pathology, said: “We have a 25-year old LIMS that was never designed to support a network, and we have created so many workarounds that it is no longer sustainable.

"We need a LIMS that can do a lot more; one that will enable us to further harmonise our workflow and enable us to grow. WinPath Enterprise has already been deployed into large, networked environments, so we are confident that CliniSys can help us to further modernise and streamline our service."

Donald Saum, business development director at CliniSys, said: "South West London Pathology has used an integration strategy to enable information to flow between systems, but there comes a point when you need to take a consolidation approach.

"That is what WinPath Enterprise will enable the network to do, while also laying the foundations for further consolidation and growth. We are delighted to be working with the network as it takes that next step."

South West London Pathology was set up in response to a national report on pathology services conducted by Lord Carter of Coles and the Modernising Pathology in London Programme. The Carter report argued there was a strong case for the consolidation of pathology services, so non-urgent and more specialist work could be carried in laboratories with the staff and resources to ensure high-quality results.

A number of pathology networks have now been set up or are being developed in response to a second report from Lord Carteron efficiencyand the recent NHS Long Term Plan. WinPath Enterprise responds to their need for a modern LIMS that can effectively manage tests conducted at multiple sites.

At South West London Pathology, the new LIMS will have to be integrated with the electronic patient record systems used by the different partner trusts; and the seven order communications systems used to order different tests from across the network.

To support the integration, the Rhapsody integration engine that was developed by Orion Health and recently sold to Hg Capitalis being layered into the CliniSys solution and will be delivered as part of the contract.

About South West London Pathology

South West London Pathology is an award winning pathology partnership set up by St George's University Hospitals NHS Foundation Trust, Kingston Hospital NHS Foundation Trust and Croydon Health Services NHS Trust to provide a single, integrated service across south west London and beyond.

About CliniSys

The CliniSys Group has been successfully developing and deploying laboratory IT systems for over 30 years. Its first go-live was in 1987, starting rapid growth in North East Europe. The group has expanded across the UK and Belgium, into Ireland, the Netherlands and Luxembourg. CliniSys is now the market leader in all of these territories.

Headquartered in Chertsey, Surrey, CliniSys currently provides systems to in excess of 2,000 laboratories across 30 countries and employs some 230 dedicated pathology IT professionals. Since joining forces with Sunquest ICE, its software is now running in over 75% of trusts across the NHS. Please visit www.clinisys.co.uk for more information.

About WinPath Enterprise

WinPath is the UK’s leading laboratory information system (LIMS). Combining proven performance with pioneering innovation, WinPath has been specifically developed to support the challenges and opportunities facing pathology as a key clinical service within the integrated healthcare community.

As a Windows based application, WinPath delivers a familiar look and feel, is easy to navigate and intuitive in use. WinPath is a functionally rich, financially aware system, with inbuilt business intelligence tools. It is a highly flexible system that enables users to adapt to change and secure the benefits afforded through the adoption of modern and Lean workflows, service optimisation and interoperability.

With more WinPath Enterprise multi-site operations than any other LIMS provider in the UK, CliniSys has extensive experience of working with trusts to develop and implement pathology networks to ensure that the investment in the network is realised in improved patient services and reduced costs. Some of these networks cover whole counties and are mission critical for maintaining a vital support service to ensure continuity of care for major hospitals.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...